🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
KT Corp. unveils Global Epidemic Prevention Platform outside Korea

KT Corp. said its Global Epidemic Prevention Platform (GEPP) started service in Ghana on 14th, the first such ...

August 19, 2019 | Monday | News
Straumann Group to expand Warantec dental implants biz

Headquartered in Switzerland, The Straumann Group has entered into a partnership with Yuhan Corporation, Korea’s l...

August 14, 2019 | Wednesday | News
Samsung BioLogics implements N-1 perfusion for commercial application

Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...

August 13, 2019 | Tuesday | News
Gencurix reveals new study for early stage breast cancer

Gencurix, Inc., a Korea based company dedicated in development and market of innovative molecular diagnostics, has annou...

August 13, 2019 | Tuesday | News
South Korea’s pharma-biotech space to attract foreign investment

South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...

August 8, 2019 | Thursday | News
SillaJen to discontinue PHOCUS trial for advanced liver cancer

SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...

August 6, 2019 | Tuesday | News
Drive for generics sees Korea increasingly attractive to international pharma

Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceut...

August 2, 2019 | Friday | News
Samsung BioLogics, UCB sign third drug manufacturing deal

South Korea headquartered Samsung BioLogics (SBL) and Belgium based biopharmaceutical company UCB have agreed to an addi...

August 1, 2019 | Thursday | News
Mezzion Pharma announces positive results from FUEL trial

Mezzion Pharma Co. Ltd., a biotech company based in Korea, haas announced that top line data from the Phase 3 Fonta...

July 31, 2019 | Wednesday | News
LISCure Biosciences completes seed funding of $5M

LISCure Biosciences, a South Korea based biotech company that researches and develops bacteria-mediated immunotherapy, h...

July 26, 2019 | Friday | News
FDA approves arthritis drug by Samsung Bioepis

Samsung Bioepis becomes the first company to receive FDA approvals for biosimilars referencing all three first-generatio...

July 24, 2019 | Wednesday | News
Shinsung TK paves way for IoT Healthcare in Asia

Shinsung TK, a Korean company specializing in security system based on IoT (Internet of Things) technology, has become v...

July 23, 2019 | Tuesday | News
Orum Therapeutics raises $30M to advance Ab technology

South Korea based Orum Therapeutics has announced an oversubscribed $30 million Series B financing. New investors, ...

July 22, 2019 | Monday | News
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea

The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equ...

July 18, 2019 | Thursday | News
Janssen Korea launches QuickFire Challenge in Smart Healthcare

Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, on 17 July 2019, announced the launch of the Seoul Innovati...

July 18, 2019 | Thursday | News
Bukwang Pharma subsidiary raises 3 billion won

Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A...

July 15, 2019 | Monday | News
Yuyu Pharma holds campaign for enhancing corporate transparency

Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management syst...

July 12, 2019 | Friday | News
Daewoong Pharmaceutical introduced the excellence of NABOTA® (Prabotulinumtoxin A)

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in ...

July 9, 2019 | Tuesday | News